Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax(®)) in individuals aged ≥ 70 years: A randomized study of a single dose vs. two different two-dose schedules

Disease protection provided by herpes zoster (HZ) vaccination tends to reduce as age increases. This study was designed to ascertain whether a second dose of the HZ vaccine, Zostavax(®), would increase varicella zoster virus (VZV)-specific immune response among individuals aged ≥ 70 y. Individuals a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vesikari, Timo, Hardt, Roland, Rümke, Hans C., Icardi, Giancarlo, Montero, Jordi, Thomas, Stéphane, Sadorge, Christine, Fiquet, Anne
Formato: Artigo
Lenguaje:Inglês
Publicado: Landes Bioscience 2013
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3903905/
https://ncbi.nlm.nih.gov/pubmed/23319176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.23412
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares